Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial

Overview of attention for article published in Stem Cell Research & Therapy, June 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 46 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 11,665 followers.

Recently in @BioMedCentral 🔎 Scientists present a successful Phase I, control-placebo group, clinical trial of #mesenchymal stromal #CellTherapy for COVID-19-induced #ARDS patients. Full article: 🔓 https://t.co/38lRczeBc3 https://t.co/EnLvK9gWoJ

08 Jul 2022

Reply Repost Favourite

Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial https://t.co/SEK2Y2LXc1

30 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.